Novartis is committed to supporting Investigator Initiated Trials (IITs) as a part of the drug discovery and development process. Scientific research that is produced by qualified third-party investigators is key to complementing Novartis-sponsored research to help better understand the benefit/risk profile of our therapies as well as explore new opportunities to address unmet.